menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Pfizer falls in line with Trump’s 'Most Favored Nation' plan 

7 3
01.10.2025
*{box-sizing:border-box}body{margin:0;padding:0}a[x-apple-data-detectors]{color:inherit!important;text-decoration:inherit!important}#MessageViewBody a{color:inherit;text-decoration:none}p{line-height:inherit}.desktop_hide,.desktop_hide table{mso-hide:all;display:none;max-height:0;overflow:hidden}.image_block img div{display:none}sub,sup{font-size:75%;line-height:0}#converted-body .list_block ol,#converted-body .list_block ul,.body [class~=x_list_block] ol,.body [class~=x_list_block] ul,u .body .list_block ol,u .body .list_block ul{padding-left:20px} @media (max-width:620px){.desktop_hide table.icons-outer{display:inline-table!important}.image_block div.fullWidth{max-width:100%!important}.mobile_hide{display:none}.row-content{width:100%!important}.stack .column{width:100%;display:block}.mobile_hide{min-height:0;max-height:0;max-width:0;overflow:hidden;font-size:0}.desktop_hide,.desktop_hide table{display:table!important;max-height:none!important}.reverse{display:table;width:100%}.reverse .column.first{display:table-footer-group!important}.reverse .column.last{display:table-header-group!important}.row-7 td.column.first .border{padding:5px 5px 15px 25px}.row-7 td.column.last .border,.row-9 td.column.last .border{padding:5px 20px 25px 5px}.row-9 td.column.first .border{padding:5px 5px 15px 25px;border-bottom:15px solid transparent}} Click in for more news from The Hill

{beacon}

Health Care

Health Care

 

The Big Story

Pfizer falls in line with Trump’s 'Most Favored Nation' plan

Pfizer CEO Albert Bourla announced in the Oval Office that his company will offer all its prescription medications to Medicaid at discounted prices in line with the rates paid by other countries.

AP Photo/Alex Brandon

The move acceded to the demands in President Trump’s “Most Favored Nation” executive order, which aims to bring down U.S. drug prices and linking them to lower prices overseas.

“The United States is done subsidizing the health care of the rest of the world,” Trump said Tuesday.

Pfizer’s vast product portfolio includes cancer therapies like Ibrance and Xtandi as well as its COVID-19 products like its vaccine and the antiviral Paxlovid.

Trump sent a letter to drug companies in July demanding they provide preferential pricing to all Medicaid patients, required that they not give better prices to other developed countries on new drugs, create a way to sell directly to consumers and use trade policy to raise prices internationally so that revenue is reinvested into lowering American prices.

Those who refused risked facing “every tool in our arsenal to protect American families from continued abusive drug pricing practices,” according to Trump’s letter.

“With this deal that we signed today, we satisfied all four of [the] president’s requests, all four,” Bourla said.

Senior administration officials said talks are ongoing with other drugmakers, though Trump said Eli Lilly was among companies that would soon be announcing deals with the administration.

The Pfizer CEO has previously chafed against price-control measures, once calling Medicare negotiations established through the Inflation Reduction Act “not negotiation at all. It is price setting.”

Trump said he used the threat of tariffs to bring drug companies to........

© The Hill